Allworth Financial
VOR icon

Allworth Financial’s Vor Biopharma VOR Stock Holding History

Allworth Financial’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$203 Buy
11
+1
+10% +$21 ﹤0.01% 5071
2026
Q2 		$185 Sell
10
-63
-86% -$953 ﹤0.01% 4970
2026
Q1 		$1.3K Buy
73
+70
+2,333% +$987 ﹤0.01% 4493
2025
Q4 		$40 Hold
3
– – ﹤0.01% 4862
2025
Q3 		$147 Hold
3
– – ﹤0.01% 4632
2025
Q2 		$98 Buy
+3
New +$27 ﹤0.01% 4399

Other funds holding VOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nan Fung Trinity
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Johnson & Johnson
Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Allworth Financial's VOR Position: Q3 2026 in Review

Allworth Financial increased its Vor Biopharma (VOR) stake by 10% in Q3 2026, buying an estimated $21 and bringing the position to 11 shares worth $203. The position accounts for ﹤0.01% of the portfolio, ranked #5071.

Allworth Financial first reported a position in VOR in Q2 2025 and has held it in 6 quarters since. The position peaked at $1.3K in Q1 2026. 54 funds tracked by Wall St. Rank hold VOR as of Q3 2026.

  • Allworth Financial held 11 shares of Vor Biopharma worth $203 as of Q3 2026.
  • Allworth Financial bought 1 Vor Biopharma share in Q3 2026, an estimated $21.
  • Vor Biopharma made up ﹤0.01% of Allworth Financial's portfolio in Q3 2026, its #5071 holding.
  • Allworth Financial first reported a position in Vor Biopharma in Q2 2025 and has held it in 6 quarters since.
  • Allworth Financial's Vor Biopharma position peaked at $1.3K in Q1 2026.
  • 54 funds tracked by Wall St. Rank held Vor Biopharma as of Q3 2026.

Based on Allworth Financial's 13F filing for Q3 2026, filed 6 Nov 2026.